Does the use of recombinant AAV5 in pulmonary gene therapy lead to lung damage?
Martini SV, Fagundes SS, Schmidt AC, Avila M, Ornellas DS, Ribas VT, Petrs-Silva H, Linden R, Faffe DS, Guggino SE, Rocco PR, Zin WA, Morales MM.
Martini SV, et al.
Respir Physiol Neurobiol. 2009 Sep 30;168(3):203-9. doi: 10.1016/j.resp.2009.06.016. Epub 2009 Jun 30.
Respir Physiol Neurobiol. 2009.
PMID: 19573627
Free article.